20th September 2019 by Louise Hudman
This is a new guideline from NICE giving advice on ertugliflozin, published in April 2019. I am also doing a quick reminder about the other SGLT-2 inhibitors.
It is another sodium-glucose co-transporter 2 (SGLT-2) inhibitor, like canagliflozin, dapagliflozin and empagliflozin.
It is thought to be as effective as the other SGLT-2 inhibitors, but it is cheaper.
Video: Dr Varun Anand – adult obesity and weight management
Dr Varun Anand gives a webinar on adult obesity and weight management in general practice.
Finerenone for CKD in type 2 diabetes (Nice, March 2023)
This is a new guideline from Nice advising that we can use finerenone for selected patients with CKD and type 2 diabetes.
GP low-carb intervention shows 77% diabetes remission
GPs in Southport who ran a 2013-2021 study just published their results in BMJ Nutrition, Prevention and Health.
"LocumDeck helps me find GP locums quickly, and they are very easy to book on the system. "
Leanne Lincoln, Scheduling Co-ordinator, Beccles Medical Centre